|Nominee||Total AUM||Geographic focus||Fund sizes ($ and year)||# of women led portfolio companies||# of female Partners||# of women on the Investment Committee||Why this firm deserves FF recognition in 2021|
|Ada Ventures||$50m||UK||$50m, December 2019, started investing in 2020||10/18||1/2||1/2||Ada Ventures is an early-stage VC fund co-founded by Check Warner and Matt Penneycard in 2019. To date, Ada has invested in companies solving problems like affordable, flexible childcare (Bubble), mental health support for employees (Spill) and workers rights (Organise) and many more. Check is also a co-founder and CEO of non-profit Diversity VC.|
|Asia Alternatives||Leading Asia investment management firm, co-founded by Melissa Ma, Rebecca Xu and Laure Wang. Asia Alternatives is a solution platform dedicated to helping institutional investors make investments in private equity across Asia. The Firm currently manages over $13.5 billion regulatory assets under management across Asia Alternatives Capital Partners, LP (â€œAACP Iâ€) ($515 million), AACP II ($950 million), AACP III ($908 million), Asia Alternatives Capital Partners IV, LP, along with its sleeve fund focused on investments outside of Japan, AACP IV Ex-Japan Investors, LP ($1 billion) and Asia Alternatives Capital Partners V, LP along with its parallel fund, Asia Alternatives Capital Partners V (ERISA), LP ($1.515 billion), Asia-focused private equity Funds-of-Funds (FoF), plus other related fund vehicles. Asia Alternatives invests with top performing private equity fund managers across Asia, primarily in Greater China (Mainland China, Taiwan, and Hong Kong), Japan, Korea, South East Asia, India and Australia, and is diversified across buyout, growth and expansion, venture capital and special situations funds. The Firm currently has over 50 professionals and offices across Hong Kong, Beijing, Shanghai and San Francisco.|
|Hadean Ventures||205 M USD||Europe and North America||100 M USD (2017) and 105 M USD in 1st close (2021)||Female founders/CEO/CXO: 39% of portfolio companies (5 out of 13)||3 out of 6 senior team members (carry share holders)||1 out of 4 members||Dear Committee.I would like to nominate the founder of Hadean Ventures, Dr Ingrid Teigland Akay. With Hadean Ventures, Ingrid has raised the largest VC debut fund ever launched by a woman in Europe. Leveraging her success, Ingrid is focused and strong supporter of young women who aspire to have a long and successful career within venture capital and private equity, and she is seen as a true role model by many people.Led by Ingrid, Hadean Ventures has had an impressive trajectory raising funds, growing the team and building the brand of Hadean Ventures., as well as demonstrating strong investment performance. Hadean Ventures furthermore strives to have an impact on the industries it operates in, both in terms of increasing the number of female investment professionals, and actively searching for female led companies to invest in. Initiatives Hadean Ventures have led to change include:-Strict focus and policy to achieve a gender balanced team-Internship programs for women-Focus on female startup founders-Research into gender balance in startup community -Launched Level 20 in the Nordics-Founding Partner of the Women in Finance Charter in NorwayThe life science industry is inherently impactful, as the core focus is on tackling the medical challenges of tomorrow. However, it also has its challenges when it comes to diversity. I am truly impressed by the way Ingrid and her team work to change this. In recruitment processes, they proactively search until they find strong female candidates, as well as candidates with diverse backgrounds. This persistence has resulted in Hadean Ventures having a gender balanced team which is truly unique within the PE industry. These days, Ingrid and her team are launching their second fund with the same ambitions as the first. I am truly excited to see the impact Ingrid will make, both by getting new medical products to the market and making private equity a more diverse community.|
|Quan Capital||$403M in committed capital across 2 funds||Global but with China angle||Fund I: $150M, Fund II: $253M||3||3||Quan Capital is a life sciences VC firm that is led by 3 outstanding women [Samantha Du (founder of Zai Lab and Quan Capital), Marietta Wu, and Stella Xu] and the firm is 100% women owned. Quan has a global vision and capabilities to invest in emerging high potential early and growth stage companies in the fields of therapeutics and related areas, with the ultimate goal of investing in leaders with breakthrough science that can address large unmet medical needs around the world. I believe Quan deserves recognition because they are led by 3 strong female investors who are the decision makers of the firm and funds, which is unique in their sector.|
Rest of World – 2021 Female Founded Firm of the Year Nomination
© 2021 · www.pewin.org.